166 related articles for article (PubMed ID: 12725325)
1. Transfer of IkappaBalpha gene increase the sensitivity of paclitaxel mediated with caspase 3 activation in human lung cancer cell.
Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
J Exp Clin Cancer Res; 2003 Mar; 22(1):69-75. PubMed ID: 12725325
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated inhibitor kappaB gene transfer improves the chemosensitivity to anticancer drugs in human lung cancer in vitro and in vivo.
Ni J; Takayama K; Ushijima R; Inoshima N; Uchino J; Harada T; Minami T; Takeshita M; Zhou C; Nakanishi Y
Anticancer Res; 2008; 28(2A):601-8. PubMed ID: 18506998
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role.
Qiao L; Zhang H; Yu J; Francisco R; Dent P; Ebert MP; Röcken C; Farrell G
Hum Gene Ther; 2006 Mar; 17(3):280-90. PubMed ID: 16544977
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NF-kappaB inhibitor.
Chen S; Fribley A; Wang CY
J Dent Res; 2002 Feb; 81(2):98-102. PubMed ID: 11827262
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tumorigenesis and angiogenesis in vivo.
Ni J; Takayama K; Inoshima N; Uchino J; Harada A; Minami T; Harada T; Zhou C; Nakanishi Y
Anticancer Res; 2005; 25(1A):69-77. PubMed ID: 15816521
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.
Voboril R; Hochwald SN; Li J; Brank A; Weberova J; Wessels F; Moldawer LL; Camp ER; MacKay SL
J Surg Res; 2004 Aug; 120(2):178-88. PubMed ID: 15234211
[TBL] [Abstract][Full Text] [Related]
7. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.
Batra RK; Guttridge DC; Brenner DA; Dubinett SM; Baldwin AS; Boucher RC
Am J Respir Cell Mol Biol; 1999 Aug; 21(2):238-45. PubMed ID: 10423407
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.
Obara H; Takayanagi A; Hirahashi J; Tanaka K; Wakabayashi G; Matsumoto K; Shimazu M; Shimizu N; Kitajima M
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2198-204. PubMed ID: 11031204
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
Oida Y; Gopalan B; Miyahara R; Branch CD; Chiao P; Chada S; Ramesh R
Mol Cancer Ther; 2007 Apr; 6(4):1440-9. PubMed ID: 17431123
[TBL] [Abstract][Full Text] [Related]
11. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
12. The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-κB inhibition.
Caicedo-Granados EE; Wuertz BR; Marker PH; Lee GS; Ondrey FG
Arch Otolaryngol Head Neck Surg; 2011 Aug; 137(8):799-805. PubMed ID: 21844414
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenoviral gene transfer of mutated IkappaBalpha, a novel inhibitor of NF-kappaB, on human monocyte-derived dendritic cells.
Zhou LF; Zhang MS; Yin KS; Ji Y; Xie WP; Cui XF; Ji XH
Acta Pharmacol Sin; 2006 May; 27(5):609-16. PubMed ID: 16626517
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of NF-kappaB through IkappaBalpha transfection affects invasion of human lung cancer cell line A549].
Zhang J; Xu YJ; Xiong WN; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Ai Zheng; 2008 Jul; 27(7):710-5. PubMed ID: 18606063
[TBL] [Abstract][Full Text] [Related]
15. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line.
Oyaizu H; Adachi Y; Okumura T; Okigaki M; Oyaizu N; Taketani S; Ikebukuro K; Fukuhara S; Ikehara S
Oncol Rep; 2001; 8(4):825-9. PubMed ID: 11410792
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
Huang Y; Johnson KR; Norris JS; Fan W
Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated overexpression of novel mutated IkappaBalpha inhibits nuclear factor kappaB activation in endothelial cells.
Zhou LF; Yin KS; Zhu ZL; Zhu Y; Yao X; Mao H; Xie WP; Huang M
Chin Med J (Engl); 2005 Sep; 118(17):1422-8. PubMed ID: 16157044
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
